# Early Detection and Intervention for the Prevention of Psychosis

> **NCT00531518** · NA · COMPLETED · sponsor: **MaineHealth** · enrollment: 292 (actual)

## Conditions studied

- Schizophrenia
- Bipolar Disorder
- Depression
- Psychotic Disorders

## Interventions

- **DRUG:** aripiprazole; fluoxetine; bupropion; sertraline; lamotrigine
- **BEHAVIORAL:** Psychoeducational multifamily group treatment
- **BEHAVIORAL:** Supported employment and education

## Key facts

- **NCT ID:** NCT00531518
- **Lead sponsor:** MaineHealth
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2013-05
- **Final completion:** 2013-09
- **Target enrollment:** 292 (ACTUAL)
- **Last updated:** 2016-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00531518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00531518, "Early Detection and Intervention for the Prevention of Psychosis". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00531518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*